Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients

PURPOSE: Denosumab is a monoclonal antibody that prevents the development of osteoclasts. The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. The aim of this study was to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Chaiho, Kim, Hee-Je, Lee, Seok, Kang, Moo Il, Ha, Jeonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218957/
https://www.ncbi.nlm.nih.gov/pubmed/32454821
http://dx.doi.org/10.1155/2020/3410921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218957/
https://www.ncbi.nlm.nih.gov/pubmed/32454821
http://dx.doi.org/10.1155/2020/3410921

Ejemplares similares